Patient Seminar Agenda
Venue: COEX grand conference room (4th floor)
Time: April 8th (Saturday), 2006 1:00PM-5:15PM
Host: IMF, KSH, KALBD
Sponsor: Novartis
Chair : KH Kim (before coffee break), JH Lee (After coffee break), CW Suh (Q&A)
13:00-13:05
Welcome Address
S Park (Chairman, KSH)


13:05-13:10
Welcome Address
H Koh (President, KALBD)


13:10-13:20
Introduction of IMF
S Novis (President, IMF)

13:20-13:40
Introduction and myeloma in Korea
J Lee (GMC)


13:40-14:10
Diagnosis, staging and supportive care (excluding bone disease), old
Brian G.M. Durie, MD
and new
(National Director for Hematologic Malignancies, Aptium
, , ,
Oncology, Inc., Chairman, International Myeloma
Foundation)
14:10-14:30
Induction therapy
Y Kim (CNUH)
1

14:30-14:50
High-dose therapy (ASCT & AlloSCT)
S Yoon (SNUH)


14:50-15:10
Coffee Break

15:10-15:40
Management of myeloma bone disease
Gregory R. Mundy, M.D.

(Professor of Cellular & Structural Biology, University of
Texas Health Science Center)
15:40-16:00
Bortezomib
S Sohn (KNUH)


16:00-16:20
Thalidomide and derivatives
K Kim (SMC)


16:20-16:40
Overview of treatment guideline
C Suh (AMC)


16:40-17:10
Q & A

17:10-17:15
Closing Remark
K Cho ( president, KSH)

---